| Old Articles: <Older 18001-18010 Newer> |
 |
The Motley Fool November 2, 2006 Brian Lawler |
Angiotech's Study Troubles The results of recent studies in medical journals have brought the company's forecasts down. Investors, take note.  |
The Motley Fool November 2, 2006 Emil Lee |
Why I'm Holding InterActiveCorp The online middleman has powerful network advantages and sturdy cash flow. Value investors rarely find great businesses trading at reasonable valuations -- but this one is.  |
The Motley Fool November 2, 2006 Todd Wenning |
What's Wrong With American Companies? It's no secret that international stocks have outperformed their American counterparts over the past five years. But despite the great growth opportunities to be found abroad, international stocks can be challenging to research.  |
The Motley Fool November 2, 2006 Dan Caplinger |
Compound Your Diversification By being aware of the benefits of diversification, you can ensure that you take the necessary steps to protect yourself and minimize the risks that you face as an investor.  |
The Motley Fool November 2, 2006 Brian D. Pacampara |
Rogers Communicates Growth At first glance, Rogers' shares might seem to have an excessive amount of optimism baked into their price. However, given Rogers' growth prospects and position within Canada's potent wireless market, this stock might actually be a bargain just waiting to be communicated.  |
The Motley Fool November 2, 2006 Rick Aristotle Munarriz |
Guess the Weight at Cedar Fair The gains aren't quite what they seem, but the amusement-park operator isn't in bad shape. Investors, take note.  |
CFO November 1, 2006 Randy Myers |
Can You Have Your Stock and Sell It, Too? Critics contend that something is amiss when companies buy back stock at the same time executives are selling.  |
Financial Planning November 1, 2006 Mark Thurston |
Alive and Well Naysayers may be down on international stocks, but they remain an important part of a diversified portfolio strategy.  |
The Motley Fool November 1, 2006 John Reeves |
7 More Surprising 1-Star Stocks Can these stocks keep up the momentum? New River Pharmaceuticals... Acorda Therapeutics... NVE... American Power Conversion... etc.  |
The Motley Fool November 1, 2006 |
DreamWorks Dreams On: Fool by Numbers The film studio released third-quarter 2006 earnings: Income Statement Highlights... Margin Checkup... Balance Sheet Highlights... Cash Flow Highlights...  |
| <Older 18001-18010 Newer> Return to current articles. |